ስለ ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
ኢንዱስትሪBiotechnology
ዋና መሥሪያ ቤትSeattle, WA
የተመሠረተ2005
የሕግ ቅርጽC Corporation
ሁኔታንቁ
ቁልፍ አሃዞች
ቁልፍ አሃዞችን ለማየት ይግቡ
የALLOZYNE INC ገቢ፣ የተጣራ ገቢ እና የሰራተኛ ብዛት በዓመታት ሂደት፣ ከምንጮቻቸው ጋር።
ይግቡ በኢሜይልዎ መለያ ይፍጠሩነፃ ነው
በመቀጠል፣ በHeelky ተጠቃሚ ስምምነት፣ በግላዊነት ፖሊሲ እና በኩኪ ፖሊሲ ይስማማሉ።
የሕግ መረጃ
| ሕጋዊ ስም | ALLOZYNE INC |
|---|---|
| የሕግ ቅርጽ | C Corporation |
| SEC CIK | 1345630በSEC EDGAR ላይ ይመልከቱ ↗ |
| የተመዘገበ አድራሻ | Seattle, WA |
| ሁኔታ | ንቁ |
ምንጮች: SEC EDGAR · የተዘመነ Nov. 14, 2026
እውቂያ & አገናኞች
ቦታ
Seattle, WA
ይህ ኩባንያዎ ነው?
አርማዎን፣ ምርቶችዎን፣ ፎቶዎችዎን እና ሥራዎችዎን ለመጨመር እና ግምገማዎችን ለመመለስ ይህን ገጽ በነፃ ይውሰዱ።
ይህን ገጽ ይውሰዱለመገናኘት፣ ለመቅጠር እና ለማደግ Heelkyን ይቀላቀሉ
ለሰዎች መልዕክት ለመላክ፣ ለሥራ ለማመልከት እና ተልዕኮዎችን ለመለጠፍ ነፃ መለያ ይፍጠሩ።
አሁን ይቀላቀሉ — ነፃ ነው